Dr. Alok De has received his PhD from Calcutta University, India. Dr. De is a Research Biologist at Kansas City VA Medical Center, USA. His research focuses on to use extract of Emblica officinalis (Amla) as an alternative or adjunct therapeutic agent in helping to fight ovarian cancer (OC). He is characterizing components from Amla.  He is studying Amla and its components effect on regulation of microRNAs and exosomes release from OC cells and its microenvironment. He has published 46 papers in reputed journals. He has been serving as reviewers and as an editorial board member of many journals.